Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 321, pseudogene (RN7SL321P) is one of many human 7SL RNA-derived pseudogenes. Pseudogenes like RN7SL321P are typically truncated or mutated genomic copies of functional RNA genes, resulting from the reverse transcription of their parent RNAs into DNA and subsequent integration into the genome. The majority of 7SL pseudogenes do not encode functional proteins or RNAs and are generally not expressed or functional. Some pseudogenes have been shown to produce non-coding RNAs that may function as regulatory RNAs by acting as miRNA sponges, competitive endogenous RNAs (ceRNAs), or influencing gene expression via epigenetic mechanisms. However, no specific functional or disease association has been described for RN7SL321P. Unlike the canonical 7SL RNA, which is integral to the signal recognition particle (SRP) and plays a key role in protein targeting within the cell, RN7SL321P is simply a genomic relic with no demonstrated therapeutic or biomarker utility.
No established drugs target this pseudogene. Hypothetically, RNA-targeting agents could modulate ncRNA roles, but not documented for RN7SL321P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 321, pseudogene (RN7SL321P).